Literature DB >> 26511366

[Intra-articular injection of cortisone].

M Hammer1, T Schwarz2, G Ganser2.   

Abstract

Intra-articular injections with glucocorticoids are standard procedures according to therapy guidelines in many rheumatic conditions. There is increasing evidence from clinical trials on the treatment of rheumatoid arthritis that more patients will attain the target of remission using a combination of systemic medication and intra-articular injections with glucocorticoids compared to systemic medication alone. Intra-articular injections with glucocorticoids play an important role in the therapeutic management of pediatric rheumatic diseases. In many countries competency in performing intra-articular injections is among the important skills necessary for certification as a specialist in rheumatology.

Entities:  

Keywords:  Remission; Rheumatic diseases; Rheumatoid arthritis; Rheumatology; Standard therapy

Mesh:

Substances:

Year:  2015        PMID: 26511366     DOI: 10.1007/s00393-015-1626-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  23 in total

1.  Intra-articular hydrocortisone in arthritis and allied conditions; a summary of two years' clinical experience.

Authors:  J L HOLLANDER
Journal:  J Bone Joint Surg Am       Date:  1953-10       Impact factor: 5.284

2.  Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.

Authors:  Kim Hørslev-Petersen; Merete Lund Hetland; Peter Junker; Jan Pødenphant; Torkell Ellingsen; Palle Ahlquist; Hanne Lindegaard; Asta Linauskas; Annette Schlemmer; Mette Yde Dam; Ib Hansen; Hans Christian Horn; Christian Gytz Ammitzbøll; Anette Jørgensen; Sophine B Krintel; Johnny Raun; Julia S Johansen; Mikkel Østergaard; Kristian Stengaard-Pedersen
Journal:  Ann Rheum Dis       Date:  2013-02-23       Impact factor: 19.103

3.  Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.

Authors:  A Ravelli; S M Manzoni; S Viola; A Pistorio; N Ruperto; A Martini
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

4.  Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.

Authors:  Gregor Dueckers; Nihal Guellac; Martin Arbogast; Guenther Dannecker; Ivan Foeldvari; Michael Frosch; Gerd Ganser; Arnd Heiligenhaus; Gerd Horneff; Arnold Illhardt; Ina Kopp; Ruediger Krauspe; Barbara Markus; Hartmut Michels; Matthias Schneider; Wolfram Singendonk; Helmut Sitter; Marianne Spamer; Norbert Wagner; Tim Niehues
Journal:  Clin Immunol       Date:  2011-10-26       Impact factor: 3.969

5.  EULAR recommendations for calcium pyrophosphate deposition. Part II: management.

Authors:  W Zhang; M Doherty; E Pascual; V Barskova; P-A Guerne; T L Jansen; B F Leeb; F Perez-Ruiz; J Pimentao; L Punzi; P Richette; F Sivera; T Uhlig; I Watt; T Bardin
Journal:  Ann Rheum Dis       Date:  2011-01-20       Impact factor: 19.103

Review 6.  Intra-articular corticosteroid injections in juvenile idiopathic arthritis.

Authors:  A G Cleary; H D Murphy; J E Davidson
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

7.  Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).

Authors:  Marjatta Leirisalo-Repo; Hannu Kautiainen; Leena Laasonen; Markku Korpela; Markku J Kauppi; Oili Kaipiainen-Seppänen; Riitta Luosujärvi; Reijo Luukkainen; Anna Karjalainen; Harri Blåfield; Toini Uutela; Kirsti Ilva; Heikki A Julkunen; Leena Paimela; Kari Puolakka; Eeva Moilanen; Pekka J Hannonen; Timo Möttönen
Journal:  Ann Rheum Dis       Date:  2012-06-30       Impact factor: 19.103

8.  Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.

Authors:  Vappu Rantalaiho; Kari Puolakka; Markku Korpela; Pekka Hannonen; Timo Möttönen
Journal:  Clin Exp Rheumatol       Date:  2012-10-16       Impact factor: 4.473

9.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

Authors:  Catriona Grigor; Hilary Capell; Anne Stirling; Alex D McMahon; Peter Lock; Ramsay Vallance; Wilma Kincaid; Duncan Porter
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

View more
  1 in total

1.  Identification of Novel Targets of Knee Osteoarthritis Shared by Cartilage and Synovial Tissue.

Authors:  Chenshuang Li; Zhong Zheng
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.